Research
October 19, 2026
Mayo Clinic researchers found that GLP-1 receptor agonists, medications widely used for diabetes and weight management, were associated with a lower risk of dialysis or kidney transplantation in adults with bipolar disorder and chronic kidney disease.
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community